Biotech China 2014
26th Annual Symposium Cardiology for the Practitioner
Yosemite Lodge at the Falls
9004 Yosemite Lodge Drive, Yosemite National Park
Yosemite National Park, CA 95389
https://www.cme.ucsf.edu/cme/CourseDetail.aspx?coursenumber=MFR10001#CourseOutline
26th Annual Symposium Cardiology for the Practitioner
University of California, San Francisco 

Schedule of Presentations:

Monday, October 19, 2009
07:00:00 Wednesday, October 31, 3009 | Day 3
07:00:00 Tuesday, October 20, 2009 | Day 2
07:00:00 Registration - Yosemite Lodge (Cliff/Falls Room) | Day 1
07:30:00 Complimentary Continental Breakfast (For Registrants Only) | Day 1
07:30:00 Complimentary Continental Breakfast (Registrants Only) | Day 2
07:30:00 SESSION TITLE: Traditional vs. Emerging Risk Factors; Role of Risk Predictive Models; CVD in Women | Day 1 Prakash Deedwania
07:30:00 SESSION TITLE: Clinical Case Presentations, Heart Failure, Device Therapies, Cardiac Transplantation, and Perioperative Cardiac Evaluation | Day 3 Enrique V. Carbajal
07:30:00 Complimentary Continental Breakfast (Registrants Only) | Day 3
08:00:00 Case Presentations of Commonly Encountered Clinical Scenarios | Day 3 Cyrus Buhari
08:00:00 ECG Workshop: Special interactive session on ECG interpretation (Participants are encouraged to read in advance the ECG examples given in their course handbook and bring digital images of challenging ECGs.) | Day 2 Nora F. Goldschlager
08:00:00 Welcome and Introduction | Day 1 Prakash Deedwania
08:05:00 The Prevalence and Predictive Value of Traditional and Emerging Coronary Risk Factors | Day 1 Peter Wilson
08:10:00 Panel Discussion: Nora F. Goldschlager, Michael Crawford, Kanu Chatterjee, Enrique V. Carbajal, Thomas Burdon
08:30:00 SESSION TITLE: The State of the Art in Acute and Chronic Ischemic Syndromes, Atrial Fibrillation, and Mind, Body and Heart interaction | Day 2 Prakash Deedwania
08:40:00 Questions and Answers | Day 1
08:45:00 Questions and Answers | Day 3
08:50:00 Comprehensive Evaluation and Management of CVD in Women | Day 1 Rita Redberg
09:00:00 Is There Still a Role of PCI in ACS Beyond ST-Elevation MI?: The Conundrum of Antiplatelet Therapy for DES in Real Life | Day 2 John Ambrose
09:00:00 An Update on Management of Patients with Systolic and Diastolic Heart Failure. | Day 3 Kanu Chatterjee
09:30:00 Questions and Answers | Day 1
09:45:00 Questions and Answers | Day 3
09:45:00 Questions and Answers | Day 2
09:45:00 The Clinical Utility of Global Risk Assessment Tools: Framingham Risk Score vs. Others | Day 1 Peter WF Wilson
09:55:00 The Role of Newer Antianginal Drugs in Patient with CAD | Day 2 Prakash Deedwania
09:55:00 Role of AICD and Biventricular Pacing Therapy in Heart Failure | Day 3 Nora F. Goldschlager
10:20:00 Questions and Answers | Day 1
10:25:00 Questions and Answers | Day 2
10:30:00 Question and Answers | Day 3
10:30:00 Break/Meet the Faculty | Day 1
10:35:00 Break/Meet the Faculty | Day 2
10:35:00 SESSION TITLE: Global Risk Reduction, Advances in Lipid Lowering Therapy and the Role of Newer Cardiac Imaging Modalities | Day 1
10:40:00 Break/Meet the Faculty | Day 3
10:45:00 Going Beyond LDL Reduction: Is There a Role of Treatment Specifically Targeted Towards Biomarkers Such as Hs-CRP LpPla2, etc | Day 1 Mary Malloy
10:45:00 When is Revascularization Really Needed in Chronic Ischemic Syndromes? The Impact of COURAGE and BARI-2D | Day 2 Michael Crawford
10:50:00 Ventricular Assist Device and Cardiac Transplantation in Heart Failure | Day 3 Thomas Burdon
11:20:00 Question and Answers | Day 1
11:20:00 Questions and Answers | Day 2
11:30:00 The Role of Minimally Invasive Coronary Revascularization Procedures | Day 2 Thomas Burdon
11:30:00 Questions and Answers | Day 3
11:30:00 Global Risk Reduction: Primary and Secondary Prevention Strategies | Day 1 Peter WF Wilson
11:30:00 A Cost Effective Approach for Perioperative Evaluation and Management | Day 3 Michael Crawford
11:55:00 Questions and Answers | Day 2
12:00:00 Mind-Body Medicine vs. Atenolol | Day 2 Eva Weinlander
12:00:00 Questions and Answers | Day 1
12:10:00 Critical Appraisal of the Clinical Utility and Limitations of Newer Cardiac Imaging Modalities in the Evaluation of Cardiac Patients: CT Angio, EBCT, MRI, etc. | Day 1 Rita Redberg
12:30:00 Questions and Answers | Day 2
12:35:00 Emerging Therapeutic Strategies in Atrial Fibrillation: Role of Rate vs. Rhythm Control and Chronic Anticoagulation: The Role of Newer Drugs | Day 2 Nora F. Goldschlager
12:45:00 Questions and Answers | Day 1
12:55:00 Emerging Role of Genomics in Identifying Patients at High Risk of Cardiovascular Disease | Day 1 John Kane
13:15:00 Questions and Answers | Day 3
13:25:00 Questions and Answers | Day 1
13:25:00 Questions and Answers | Day 2
13:30:00 Adjourn | Day 3
13:35:00 Adjourn | Day 2
13:35:00 Adjourn | Day 1
15:00:00 Tuesday Evening | Day 2
15:00:00 Monday Evening | Day 1
18:00:00 Meet the Experts (Each participant may attend both sessions, which will be 45 minutes each.) | Day 1
18:00:00 Cardiac Auscultation Workshop Using Commonly Encountered Clinical Scenarios: What Do I Hear and What Does It Mean? | Day 2 Kanu Chatterjee
18:05:00 B) Practical Issues in the Management of Patients with Acute and Chronic Ischemic Syndromes | Day 1 Prakash Deedwania, Michael Crawford, John Ambrose
18:05:00 A) Practical Issues in the Management of Patients with Hypertension, Diabetes, and Dyslipidemia | Day 1 John Kane
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.